Panagene Inc
Panagene Inc. develops products in the field of molecular diagnostics in South Korea. Its products include Liquid biopsy products for lung and colon cancers; tissue biopsy products for lung, thyroid, pancreatic, and colon cancers, as well as glioblastoma, myeloproliferative neoplasm, chronic myelogenous leukemia, central nervous system, myelofibrosis, and polycythemia vera diseases. The company a… Read more
Panagene Inc (046210) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.001x
Based on the latest financial reports, Panagene Inc (046210) has a cash flow conversion efficiency ratio of 0.001x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩46.17 Million) by net assets (₩77.27 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Panagene Inc - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Panagene Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Panagene Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Panagene Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Caprice Resources Limited
F:C3F
|
-0.006x |
|
Acrinova AB Series B
ST:ACRI-B
|
0.342x |
|
Romsdal Sparebank
OL:ROMSB
|
N/A |
|
Bo Lak
KO:002760
|
0.039x |
|
Daebo Magnetic Co.Ltd
KQ:290670
|
-0.063x |
|
European Lithium Limited
OTCQB:EULIF
|
0.571x |
|
HI SPAC 3
KQ:217500
|
-0.025x |
|
Tainet Communication System
TWO:4905
|
0.016x |
Annual Cash Flow Conversion Efficiency for Panagene Inc (2006–2024)
The table below shows the annual cash flow conversion efficiency of Panagene Inc from 2006 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩76.04 Billion | ₩346.54 Million | 0.005x | +701.91% |
| 2023-12-31 | ₩63.57 Billion | ₩36.13 Million | 0.001x | -99.46% |
| 2022-12-31 | ₩31.69 Billion | ₩3.36 Billion | 0.106x | -47.35% |
| 2021-12-31 | ₩29.84 Billion | ₩6.01 Billion | 0.201x | +19.31% |
| 2020-12-31 | ₩25.07 Billion | ₩4.23 Billion | 0.169x | +225.83% |
| 2019-12-31 | ₩20.20 Billion | ₩1.05 Billion | 0.052x | -17.13% |
| 2018-12-31 | ₩16.30 Billion | ₩1.02 Billion | 0.063x | +158.64% |
| 2017-12-31 | ₩19.84 Billion | ₩-2.12 Billion | -0.107x | -100.63% |
| 2016-12-31 | ₩21.10 Billion | ₩-1.12 Billion | -0.053x | -30.35% |
| 2015-12-31 | ₩8.91 Billion | ₩-363.21 Million | -0.041x | -107.56% |
| 2012-12-31 | ₩8.92 Billion | ₩4.81 Billion | 0.539x | +333.48% |
| 2011-12-31 | ₩15.94 Billion | ₩-3.68 Billion | -0.231x | -104.70% |
| 2010-12-31 | ₩16.66 Billion | ₩-1.88 Billion | -0.113x | +53.02% |
| 2009-12-31 | ₩17.92 Billion | ₩-4.31 Billion | -0.240x | -514.69% |
| 2008-12-31 | ₩25.88 Billion | ₩1.50 Billion | 0.058x | -7.83% |
| 2007-12-31 | ₩34.14 Billion | ₩2.15 Billion | 0.063x | +41.98% |
| 2006-12-31 | ₩30.94 Billion | ₩1.37 Billion | 0.044x | -- |